Author

K. S. Smythe

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

A. G. Chapuis· 1 shared A. J. Wisdom· 1 shared A. Rongvaux· 1 shared C. L. Kent· 1 shared C. S. Hong· 1 shared D. G. Kirsch· 1 shared D. J. Carpenter· 1 shared D. R. Byrd· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. G. Chapuis

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A faithful in vivo model of human macrophages in metastatic melanoma

V. Voillet, T. R. Berger, K. M. McKenna, K. G. Paulson, K. S. Smythe, D. S. Hunter, W. J. Valente, S. J. Weaver, J. S. Campbell, T. S. Kim, D. R. Byrd, J. H. Bielas, R. H. Pierce, A. G. Chapuis, R. Gottardo, A. Rongvaux

The paper develops a humanized mouse model of metastatic melanoma that supports tumor spread and recapitulates patient macrophage transcriptomes, linking them to poor survival.

bioRxiv · Sep 9, 2021 · PreprintImmunology

A single cell atlas reveals distinct immune landscapes in transplant and primary tumors that determine response or resistance to immunotherapy

A. J. Wisdom, Y. M. Mowery, C. S. Hong, X. Qin, D. Zhang, J. E. Himes, L. Chen, H. Fradin, E. S. Muise, E. S. Xu, D. J. Carpenter, C. L. Kent, K. S. Smythe, N. Williams, L. Luo, , D. G. Kirsch

The paper compares immune landscapes in transplant and primary tumors after immunotherapy and radiotherapy, finding that transplant tumors respond better due to CD8+ T cell enrichment.

bioRxiv · Mar 11, 2020Cancer Biology